# 10x Genomics, Inc. (TXG) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from 10x Genomics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TXG/mda/fy2025/): filed 2026-02-13; accession 0001628280-26-007822 (https://www.sec.gov/Archives/edgar/data/1770787/000162828026007822/txg-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TXG/mda/fy2024/): filed 2025-02-13; accession 0001770787-25-000013 (https://www.sec.gov/Archives/edgar/data/1770787/000177078725000013/txg-20241231.htm)
- [FY 2023 MD&A](/company/TXG/mda/fy2023/): filed 2024-02-15; accession 0001770787-24-000017 (https://www.sec.gov/Archives/edgar/data/1770787/000177078724000017/txg-20231231.htm)
- [FY 2022 MD&A](/company/TXG/mda/fy2022/): filed 2023-02-16; accession 0001770787-23-000012 (https://www.sec.gov/Archives/edgar/data/1770787/000177078723000012/txg-20221231.htm)
- [FY 2021 MD&A](/company/TXG/mda/fy2021/): filed 2022-02-18; accession 0001770787-22-000015 (https://www.sec.gov/Archives/edgar/data/1770787/000177078722000015/txg-20211231.htm)

Back to /company/TXG/